Guardado en:
| Autores principales: | Snehadhar Shah, Jonathan Ince, Roger Kockelbergh |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.325 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
por: Liam Mannion, et al.
Publicado: (2024)
por: Liam Mannion, et al.
Publicado: (2024)
Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
por: Serdar Turan, et al.
Publicado: (2025)
por: Serdar Turan, et al.
Publicado: (2025)
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
por: Liwu Guo, et al.
Publicado: (2024)
por: Liwu Guo, et al.
Publicado: (2024)
Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
por: Hugo Klempfner, et al.
Publicado: (2024)
por: Hugo Klempfner, et al.
Publicado: (2024)
Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
por: Yin Zhou, et al.
Publicado: (2024)
por: Yin Zhou, et al.
Publicado: (2024)
Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
por: Alison Hiong, et al.
Publicado: (2025)
por: Alison Hiong, et al.
Publicado: (2025)
Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
por: Katherina Y. Chen, et al.
Publicado: (2026)
por: Katherina Y. Chen, et al.
Publicado: (2026)
Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
por: Chase Peng Yun Ng, et al.
Publicado: (2025)
por: Chase Peng Yun Ng, et al.
Publicado: (2025)
Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
por: Shugo Yajima, et al.
Publicado: (2025)
por: Shugo Yajima, et al.
Publicado: (2025)
Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
por: Yu Ishizuya, et al.
Publicado: (2026)
por: Yu Ishizuya, et al.
Publicado: (2026)
Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
por: Makito Miyake, et al.
Publicado: (2025)
por: Makito Miyake, et al.
Publicado: (2025)
Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
por: Sean Lim, et al.
Publicado: (2026)
por: Sean Lim, et al.
Publicado: (2026)
Malignant upper urinary tract obstruction in cancer patients: A systematic review
por: Max Shah, et al.
Publicado: (2024)
por: Max Shah, et al.
Publicado: (2024)
Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
por: Cameron E. Alexander, et al.
Publicado: (2024)
por: Cameron E. Alexander, et al.
Publicado: (2024)
The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
por: Kunal K. Sindhu, et al.
Publicado: (2024)
por: Kunal K. Sindhu, et al.
Publicado: (2024)
Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
por: Rodolfo Hurle, et al.
Publicado: (2025)
por: Rodolfo Hurle, et al.
Publicado: (2025)
Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
por: Mohammed Al‐Zubaidi, et al.
Publicado: (2024)
por: Mohammed Al‐Zubaidi, et al.
Publicado: (2024)
Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
por: Jacob Hanna, et al.
Publicado: (2026)
por: Jacob Hanna, et al.
Publicado: (2026)
Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
por: Rachel Weng, et al.
Publicado: (2025)
por: Rachel Weng, et al.
Publicado: (2025)
Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
por: Rebecca Martin, et al.
Publicado: (2025)
por: Rebecca Martin, et al.
Publicado: (2025)
A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
por: John Lahoud, et al.
Publicado: (2024)
por: John Lahoud, et al.
Publicado: (2024)
Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
por: Thomas Philip Cahill, et al.
Publicado: (2024)
por: Thomas Philip Cahill, et al.
Publicado: (2024)
Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
por: Amandeep Arora, et al.
Publicado: (2025)
por: Amandeep Arora, et al.
Publicado: (2025)
Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
por: Kylie Yen‐Yi Lim, et al.
Publicado: (2025)
por: Kylie Yen‐Yi Lim, et al.
Publicado: (2025)
Health utility value of overactive bladder in Japanese older adults
por: Takashi Yoshioka, et al.
Publicado: (2024)
por: Takashi Yoshioka, et al.
Publicado: (2024)
Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
por: Joshua D. Cabral, et al.
Publicado: (2026)
por: Joshua D. Cabral, et al.
Publicado: (2026)
A pilot study evaluating the safety and efficacy of En‐bloc holmium laser enucleation of the prostate in patients with a history of radiation therapy or high intensity focused ultrasound for management of organ confined prostate cancer with review of the literature
por: Renil S. Titus, et al.
Publicado: (2025)
por: Renil S. Titus, et al.
Publicado: (2025)
‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
por: Ryan Sutherland, et al.
Publicado: (2024)
por: Ryan Sutherland, et al.
Publicado: (2024)
Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery
por: Sezgin Yeni, et al.
Publicado: (2025)
por: Sezgin Yeni, et al.
Publicado: (2025)
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
por: Kira Furlano, et al.
Publicado: (2024)
por: Kira Furlano, et al.
Publicado: (2024)
Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder
por: William Chui, et al.
Publicado: (2024)
por: William Chui, et al.
Publicado: (2024)
Metabolic abnormalities in pure vs. mixed struvite stone formers: A retrospective comparative analysis utilising large language models for data extraction
por: Juanita Velasquez Ospina, et al.
Publicado: (2025)
por: Juanita Velasquez Ospina, et al.
Publicado: (2025)
Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
por: Samantha Shekar, et al.
Publicado: (2025)
por: Samantha Shekar, et al.
Publicado: (2025)
Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
por: Stephen Langley, et al.
Publicado: (2024)
por: Stephen Langley, et al.
Publicado: (2024)
Therapy de‐escalation for testicular cancer (THERATEST): A multi‐centre observational cohort feasibility study of de‐escalation therapies for good prognosis stage II germ cell tumours
por: Nasreen Abdul Aziz, et al.
Publicado: (2025)
por: Nasreen Abdul Aziz, et al.
Publicado: (2025)
Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
por: Angelo Porreca, et al.
Publicado: (2025)
por: Angelo Porreca, et al.
Publicado: (2025)
AI‐driven preoperative risk assessment in kidney cancer surgery: A comparative feasibility study of machine learning models
por: Julia Mühlbauer, et al.
Publicado: (2025)
por: Julia Mühlbauer, et al.
Publicado: (2025)
Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
por: Eric V. Li, et al.
Publicado: (2024)
por: Eric V. Li, et al.
Publicado: (2024)
Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies
por: Laurence Klotz, et al.
Publicado: (2024)
por: Laurence Klotz, et al.
Publicado: (2024)
Ejemplares similares
-
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
por: Liam Mannion, et al.
Publicado: (2024) -
Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
por: Serdar Turan, et al.
Publicado: (2025) -
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024) -
Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
por: Liwu Guo, et al.
Publicado: (2024) -
Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
por: Hugo Klempfner, et al.
Publicado: (2024)